Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production.

Donald L Jarvis1

  • 1Department of Molecular Biology, University of Wyoming, P.O. Box 3944, Laramie, WY 82071-3944, USA. DLJarvis@uwyo.edu

Virology
|June 6, 2003
PubMed
Summary

The baculovirus-insect cell system struggles with authentic glycoprotein production. New insect cell lines and vectors now enable humanized oligosaccharide side chains for recombinant glycoproteins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Host ranges of Sf-rhabdoviruses harbored by lepidopteran insects and insect cell lines.

Virology·2023
Same author

A new insect cell line engineered to produce recombinant glycoproteins with cleavable N-glycans.

The Journal of biological chemistry·2021
Same author

A New Bacmid for Customized Protein Glycosylation Pathway Engineering in the Baculovirus-Insect Cell System.

ACS chemical biology·2021
Same author

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.

PloS one·2021
Same author

Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.

British journal of cancer·2020
Same author

A new nodavirus-negative Trichoplusia ni cell line for baculovirus-mediated protein production.

Biotechnology and bioengineering·2020

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Glycoscience

Background:

  • The baculovirus-insect cell expression system is a common tool for producing recombinant glycoproteins for biomedical uses.
  • Insect cells possess distinct protein glycosylation pathways, limiting the production of mammalian glycoproteins with native oligosaccharide structures.
  • This limitation hinders the development of therapeutic glycoproteins requiring precise glycosylation.

Purpose of the Study:

  • To review current knowledge of insect protein glycosylation pathways.
  • To present recent advancements in engineering insect cells and baculoviral vectors.
  • To enable the production of recombinant glycoproteins with humanized oligosaccharide side chains.

Main Methods:

  • Review of existing literature on insect glycosylation.

Related Experiment Videos

  • Development of novel insect cell lines with modified glycosylation machinery.
  • Engineering of baculoviral vectors for enhanced glycoprotein processing.

    • Main Results:

    • Characterization of insect protein glycosylation pathways.
    • Successful generation of insect cell lines capable of human-like glycosylation.
    • Demonstration of recombinant glycoproteins with humanized oligosaccharide structures produced using engineered systems.

    Conclusions:

    • The limitations of insect glycosylation can be overcome through genetic engineering.
    • Developed insect cell lines and vectors offer a promising platform for producing therapeutic glycoproteins with authentic human glycosylation patterns.
    • This advancement has significant implications for biopharmaceutical development and production.